Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10016


Purpose:

To determine if the use of oral Diindolylmethante (DIM), a marketed cruciferous vegetable based dietary supplement (Bioresponse-DIM), is associated with the regression of cervical dysplasia in otherwise healthy women.


Study summary:

To determine if the use of oral Diindolylmethane (DIM), a marketed cruciferous vegetable based dietary supplement (BioResponse-DIM®), is associated with the regression of cervical dysplasia in otherwise healthy women. Additionally, the study aims to see how the use of the BioResponse-DIM supplement correlates with cervical HPV colonization, and to asses the tolerability of daily DIM supplementation


Criteria:

Inclusion Criteria: - Non pregnant women greater than or equal to 18 years of age able to consent - CIN II or III confirmed by histology - Karnofsky performance status >= 80 - No prior treatment for dysplasia in the past 4 months Exclusion Criteria: - Incompletely visible lesion - Diethylstilbestrol (DES) exposure - HIV seropositive


NCT ID:

NCT00212381


Primary Contact:

Study Director
Giuseppe Del Priore, M.D., M.P.H.
NY Downtown Hospital


Backup Contact:

N/A


Location Contact:

New York, New York 10016
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.